Overview

Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To compare the effect of rosuvastatin to protease inhibitor switching on fasting total cholesterol over 12 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Juan A. Arnaiz
Treatments:
HIV Protease Inhibitors
Protease Inhibitors
Ritonavir
Rosuvastatin Calcium